CD47 supports cells in evading phagocytosis by macrophages in leukemic cancer cells, and much enthusiasm has been put behind this pathway as evidenced by multiple compounds being developed to target this checkpoint in AML (Table 1). The gene discussed is CD47; the disease is acute myeloid leukemia.